Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
 
Register | Sign in
Home Page > Videos > DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
  Videos

Return

DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
DeNovix, Inc.

The patent pending DS-11 spectrophotometer rapidly quantifies 0.5 – 1.5 ul samples of nucleic acids and proteins. The stand-alone unit includes an Android™ based operating system that does not require a PC. The DS-11 meets or exceeds the performance specifications of the market leading microvolume spectrophotometer while saving space, time and money. Free one-week trials are available for US & UK* customers. DeNovix pays the shipping costs to and from your lab for evaluation. See website for details. The system features a glove compatible, 7” HD touch screen. The DS-11 includes Wi-Fi, USB, and Ethernet connectivity, allowing users to easily export data via email, a USB drive, or via an optional printer. Measurements are made using intuitive EasyApps® designed for the most common life science applications. Rapidly quantify DNA, ssDNA, RNA, purified proteins, labeled proteins, or obtain user defined spectrophotometric measurements using the pre-installed apps. The DS-11 is a full spectrum (190-840nm) UV-Vis spectrophotometer and measures the broadest concentration range of any microvolume spectrophotometer. Options include three color choices and an optional model that includes both microvolume and cuvette modes (DS-11+). With SmartPath® Technology, the DS-11 provides reliable 1uL sample results every time. The instrument's opto-mechanical components and proprietary algorithms together provide pathlength control and performance unmatched by any microvolume and spectrophotometer. Benefits of SmartPath Technology: » No recalibration time or expense » Measure proteins with confidence » Results in 4 seconds - no dilutions required » Broadest dynamic range: 0.04 - 500 AU (1 cm equivalent) Measurement range: 2.0 - 25,000 ng/µL dsDNA and 0.10 - 750 mg/ml BSA For more information about the DeNovix DS-11 Microvolume Spectrophotometer, or to locate distributors and representatives visit: http://www.denovix.com About DeNovix Inc.: DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company’s first product, the DS-11 Spectrophotometer, is the first stand-alone microvolume spectrophotometer that is controlled by a built-in Android™ operating system. The instrument, used for quantification of nucleic acids and proteins, features an easy to use brilliant touch screen interface, Wi-Fi and Ethernet connectivity, four-second measurement time; three color choices and two model choices. *UK trial offer not valid for Northern Ireland.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Eppendorf Award for Young European Investigators 2015: Call for Entries!
Eppendorf Award celebrates 20 years in 2015.
BPA Exposure by Infants May Increase Risk of Food Intolerance
Exposure to Bisphenol A at a dose significantly below the current FDA Tolerable Daily Intake predisposes offspring to food intolerance at adulthood.
Scientists Generate First Human Stomach Tissue in Lab with Stem Cells
Unprecedented tool for researching the development and diseases of an organ central to several public health crises.
Accelerating Spirocyclic Polyketide Synthesis
Powerful flow chemistry techniques used for complex multi-stage synthesis of spirocyclic polyketides.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
First Atlas of Body Clock Gene Expression in Mammals Informs Timing of Drug Delivery
Penn Medicine study has implications for 100 top-selling US drugs, half of which target daily-oscillating genes.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Blood Test Developed to Diagnose Early Onset Alzheimer’s Disease
New blood-test could predict a person’s risk of developing AD much earlier than is currently possible.
Tea and Citrus Products Could Lower Ovarian Cancer Risk
New UEA research finds that women who consume foods containing flavonols and flavanones significantly decrease their risk of developing epithelial ovarian cancer.
TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv